Demand For Surgical Heart Valves Projected To Slowly Decline
Executive Summary
The market for surgical heart valve replacement devices is projected to steadily decline, as newer, more innovative transcatheter techniques poach customers, according to a new report from Informa’s Meddevicetracker.
You may also be interested in...
Abbott Adds New Surgical Tissue Valves
The US FDA approved Abbott’s new Epic Plus stented tissue mitral valve and Epic Plus Supra stented tissue aortic valve.
Minute Insight: Confidence Plus Shows Medical Device Innovation Can Start In The Home
Ostomy bags can leak and cause problems for patients and health care workers, so Anne Inch created a device in her attic to solve that problem and has begun to commercialize it.
Digital Health Roundup: Digital Therapeutics, Restoring Function, Deals, Investing And Lobbying
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights the push behind digital therapeutics, Abbott’s biowearable line, Exec Chats with iRhythm and Cognetivity, Right To Repair rules for tech, and FDA's guidance on 3D-printing.